Company
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals has 3 drugs tracked on RxWires: 2 in Phase 3, 1 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Avexitide | Phase 3 | Post Bariatric Hypoglycemia |
| AMX0035 | Phase 3 | Amyotrophic Lateral Sclerosis |
| AMX0114 | Phase 1 | ALS |
Latest
- amylyx pharmaceuticals filed 8-K
- amylyx pharmaceuticals filed 8-K
- amylyx pharmaceuticals filed 8-K
- amylyx pharmaceuticals filed 8-K
- amylyx pharmaceuticals filed 8-K
Follow Amylyx Pharmaceuticals on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.